Heinrich et al., 1984), were found in the additional sequence of proglucagon
The evidence for tirzepatide is robust, its safety profile is well-characterized, and the metabolic benefits of even partial weight reduction are not trivial
Tatarkiewicz K, Belanger P, Gu G, Parkes D, and Roy D
Anthropometric changes Some studies compared the liraglutide 1.8 mg/day vs
The starting dose in the standard published protocol is 2mg
While those results are encouraging, direct comparisons between Retatrutide and tirzepatide should be interpreted carefully because the medications have been studied in different clinical trials with different patient populations, treatment durations, and study designs